IVT aflibercept

DRUG4 trials

Sponsors

Clearside Biomedical, Inc.

Conditions

Diabetic Macular EdemaMacular EdemaRetinal Vein Occlusion

Phase 1

Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema

CompletedNCT02949024

Clearside Biomedical, Inc.Diabetic Macular Edema

Start: 2016-11-10End: 2017-10-17Updated: 2021-05-13

Phase 2

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

CompletedNCT02303184

Clearside Biomedical, Inc.Macular Edema, Retinal Vein Occlusion

Start: 2015-01-31End: 2016-03-31Updated: 2021-02-08

Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema

CompletedNCT03126786

Clearside Biomedical, Inc.Diabetic Macular Edema

Start: 2017-07-11End: 2018-04-17Updated: 2021-05-13

Phase 3

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

TerminatedNCT02980874

Clearside Biomedical, Inc.Macular Edema, Retinal Vein Occlusion

Start: 2017-01-31End: 2018-12-10Updated: 2021-04-14

Related Papers

Viral Vector Technologies and Strategies: Improving on Nature

International Ophthalmology Clinics2021-07-015 citations